COVID-19 pandemic caused surge in MDA5 disease
6:31
Video Abstract: Long-Term Prognosis of anti-MDA5–Positive DM-ILD
10:29
Lung Disease in Rare Autoimmune Conditions
11:13
Anti-MDA5 Antibody for Diagnosis and Prognosis of DM with ILD: Webinar by Dr. Ran Nakashima
2:25
Understanding TIF1‑γ and MDA5 Antibodies in Dermatomyositis | Antibody Series Part 1
2:00
Anti MDA5 Dermatomyositis
5:32
COVID-19 Triggered Anti-MDA-5 Antibody: Innocent Bystander or Culprit? Dr. Smarika Saptoka at RWCS22
5:27
Interview with Dr. Mark McPherson- Management of MDA-5 ILD
3:43
Type I interferon in anti-MDA5 dermatomyositis, S.H. Zhang et al.
11:01
Diagnosis : Anti-synthetases syndrome and anti-MDA5 dermatomyositis (Part 1/2)
1:57
Hand Manifestations That May Signal Dermatomyositis
5:41
Dermatomyositis patient: Woman's journey with an uncommon skin and muscle disease
1:15
Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement